Pros and cons of the use of antihistamines in managing allergic rhinitis

被引：14

作者：

Day, J ^{[1
]}

机构：

[1] Queens Univ, Dept Med, Div Allergy & Immunol, Kingston, ON K7L 3N6, Canada

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 1999年 / 103卷 / 03期

关键词：

D O I：

10.1016/S0091-6749(99)70219-8

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Histamine H-1-receptor antagonists are generally considered first-line therapy for the management of allergic rhinitis, Other than histamine antagonism, several of the second-generation antihistamines have also shown inhibitory effects on chemical mediators of inflammation such as leukotrienes, prostaglandins, and kinins, This article reviews the pharmacology, clinical use, and side effect profiles of the commonly used H-1-receptor antagonists.

引用

页码：S395 / S399

页数：5

共 53 条

[11] CETIRIZINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL POTENTIAL IN ALLERGIC RHINITIS, POLLEN-INDUCED ASTHMA, AND CHRONIC URTICARIA [J].

CAMPOLIRICHARDS, DM ;

BUCKLEY, MMT ;

FITTON, A .

DRUGS, 1990, 40 (05) :762-781

[12] EFFECT OF CETIRIZINE ON MAST CELL-MEDIATOR RELEASE AND CELLULAR TRAFFIC DURING THE CUTANEOUS LATE-PHASE REACTION [J].

CHARLESWORTH, EN ;

KAGEYSOBOTKA, A ;

NORMAN, PS ;

LICHTENSTEIN, LM .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 83 (05) :905-912

[13] LEUKOTRIENE B-4 PRODUCTION BY BLOOD NEUTROPHILS IN ALLERGIC RHINITIS - EFFECTS OF CETIRIZINE [J].

CHERIASAMMARI, S ;

ALOUI, R ;

GORMAND, F ;

CHABANNES, B ;

GALLET, H ;

GROSCLAUDE, M ;

MELAC, M ;

RIHOUX, JP ;

PERRINFAYOLLE, M ;

LAGARDE, M ;

PACHECO, Y .

CLINICAL AND EXPERIMENTAL ALLERGY, 1995, 25 (08) :729-736

[14]

Ciprandi G, 1997, CLIN EXP ALLERGY, V27, P1175

[15] Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: An antiallergic activity [J].

Ciprandi, G ;

Pronzato, C ;

Passalacqua, G ;

Ricca, V ;

Bagnasco, M ;

Grogen, J ;

Mela, GS ;

Canonica, GW .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (06) :1088-1096

[16] PROTECTIVE EFFECT OF LORATADINE ON LATE PHASE REACTION INDUCED BY CONJUNCTIVAL PROVOCATION TEST [J].

CIPRANDI, G ;

BUSCAGLIA, S ;

MARCHESI, E ;

DANZIG, M ;

CUSS, F ;

CANONICA, GW .

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1993, 100 (02) :185-189

[17] LORATADINE - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC PROPERTIES AND THERAPEUTIC EFFICACY [J].

CLISSOLD, SP ;

SORKIN, EM ;

GOA, KL .

DRUGS, 1989, 37 (01) :42-57

[18] Cetirizine, Ioratadine, or placebo in subjects with seasonal allergic rhinitis: Effects after controlled ragweed pollen challenge in an environmental exposure unit [J].

Day, JH ;

Briscoe, M ;

Widlitz, MD .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (05) :638-645

[19]

DOUGLAS WW, 1980, PHARMACOL BASIS THER, P622

[20] H-1-RECEPTOR ANTAGONISTS - COMPARATIVE TOLERABILITY AND SAFETY [J].

ESTELLE, F ;

SIMONS, R .

DRUG SAFETY, 1994, 10 (05) :350-380

← 1 2 3 4 5 6 →